Characteristics of motor vehicle crashes associated with seizure
Car crash semiology
Citation Manager Formats
Make Comment
See Comments

This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.
Abstract
Objective To examine the characteristics of seizure-related vehicle crashes (SRC).
Method Using a nested case-control design, we identified and compared cases of SRC involving confirmed epilepsy patients with 137,126 non-seizure-related crash controls (NSRC) in the Australian state of Victoria. SRC were identified from approximately 20,000 epileptologist medical records by cross-referencing this source with the Victorian Police Traffic Incident database and the Road Crash Information System Database (RCISD).
Results Seventy-one SRC involving 62 patients with epilepsy were identified. Thirty-seven SRC resulted in injury and could be identified in the RCISD and compared to NSRC. Seizure-related crashes typically involved a single vehicle (57% vs 29%, p < 0.001) carrying a sole occupant (95% vs 48%, p = 0.001). Most SRC began with an “out of control movement” (51% vs 10%, p < 0.001) and the subsequent collision type differed significantly between the groups (p < 0.001). The majority of SRC were a “collision with a fixed object” (54% vs 17%, p < 0.001) involving an “off path on straight” mechanism (48% vs 10%, p < 0.001). Regarding all 71 SRC, generalized as compared with focal epilepsy crashes involved younger drivers (p < 0.001), seizure-provoking factors (p = 0.033), and occurred earlier in the day (p = 0.004).
Conclusions Given the distinct SRC features, we propose that clinicians, crash investigators, and driver licensing authorities incorporate collision characteristics into the overall assessment of suspected SRC. Further research should examine restricting driving immediately after risk periods as a harm-minimization strategy.
Glossary
- AED=
- antiepileptic drug;
- DCA=
- Definition for Classifying Accidents;
- DLA=
- Driver Licensing Authority;
- FBTCS=
- focal to bilateral tonic-clonic seizure;
- FIAS=
- focal impaired awareness seizure;
- GTCS=
- generalized tonic-clonic seizure;
- IGE=
- idiopathic generalized epilepsy;
- ILAE=
- International League Against Epilepsy;
- MVC=
- motor vehicle crash;
- NSRC=
- non-seizure-related crashes;
- PNES=
- psychogenic nonepileptic seizures;
- RCISD=
- Road Crash Information System Database;
- SRC=
- seizure-related crashes;
- UTCS=
- unknown onset tonic-clonic seizure;
- VPTID=
- Victorian Police Traffic Incident System Database
Footnotes
Go to Neurology.org/N for full disclosures. Funding information and disclosures deemed relevant by the authors, if any, are provided at the end of the article.
Editorial page 543
CME Course: NPub.org/cmelist
- Received January 29, 2018.
- Accepted in final form June 11, 2018.
- © 2018 American Academy of Neurology
AAN Members
We have changed the login procedure to improve access between AAN.com and the Neurology journals. If you are experiencing issues, please log out of AAN.com and clear history and cookies. (For instructions by browser, please click the instruction pages below). After clearing, choose preferred Journal and select login for AAN Members. You will be redirected to a login page where you can log in with your AAN ID number and password. When you are returned to the Journal, your name should appear at the top right of the page.
AAN Non-Member Subscribers
Purchase access
For assistance, please contact:
AAN Members (800) 879-1960 or (612) 928-6000 (International)
Non-AAN Member subscribers (800) 638-3030 or (301) 223-2300 option 3, select 1 (international)
Sign Up
Information on how to subscribe to Neurology and Neurology: Clinical Practice can be found here
Purchase
Individual access to articles is available through the Add to Cart option on the article page. Access for 1 day (from the computer you are currently using) is US$ 39.00. Pay-per-view content is for the use of the payee only, and content may not be further distributed by print or electronic means. The payee may view, download, and/or print the article for his/her personal, scholarly, research, and educational use. Distributing copies (electronic or otherwise) of the article is not allowed.
Letters: Rapid online correspondence
REQUIREMENTS
You must ensure that your Disclosures have been updated within the previous six months. Please go to our Submission Site to add or update your Disclosure information.
Your co-authors must send a completed Publishing Agreement Form to Neurology Staff (not necessary for the lead/corresponding author as the form below will suffice) before you upload your comment.
If you are responding to a comment that was written about an article you originally authored:
You (and co-authors) do not need to fill out forms or check disclosures as author forms are still valid
and apply to letter.
Submission specifications:
- Submissions must be < 200 words with < 5 references. Reference 1 must be the article on which you are commenting.
- Submissions should not have more than 5 authors. (Exception: original author replies can include all original authors of the article)
- Submit only on articles published within 6 months of issue date.
- Do not be redundant. Read any comments already posted on the article prior to submission.
- Submitted comments are subject to editing and editor review prior to posting.
You May Also be Interested in
More Online
Dr. Jessica Ailani and Dr. Ailna Masters-Israilov
► Watch
Related Articles
Topics Discussed
Alert Me
Recommended articles
-
Articles
Is the underlying cause of epilepsy a major prognostic factor for recurrence?F. Semah, M.-C. Picot, C. Adam et al.Neurology, November 01, 1998 -
Article
Safety and Efficacy of Divalproex Sodium Monotherapy in Partial EpilepsyA Double-blind, Concentration-response Design Clinical TrialA. Beydoun, J. C. Sackellares, V. Shu et al.Neurology, January 01, 1997 -
Articles
Genetic influences on myoclonic and absence seizuresM. R. Winawer, D. Rabinowitz, T. A. Pedley et al.Neurology, December 08, 2003 -
Articles
Placebo-controlled study of levetiracetam in idiopathic generalized epilepsyS. F. Berkovic, R. C. Knowlton, R. F. Leroy et al.Neurology, July 11, 2007